Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Good news for AZ, Pfizer

Posted 15 October 2020

A new survey has delivered promising news for Covid vaccine developers at the forefront of the race to offer Australians protection against the virus, revealing over two-thirds of the community will take the shot once a vaccine becomes available.

There have been suggestions in the media that vaccine hesitancy could reduce the value of pharmaceutical companies' efforts to provide a vaccine in record-time.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How much to save the kid?
We paid a high price for our elderly so what about children
Special Report
Aust Covid Vaccine Tracker
UPDATES: Sanofi/GSK sign Statement of Intent with Gavi; Aust to import 3.8m vax doses
Approvals Action
Novartis' triplet inhaler ticked
First-in-class maintenance treatment of asthma